CHIKUNGUNYA: PHASE 3 CLINICAL DEVELOPMENT OF A SINGLE-SHOT LIVE-ATTENUATED VACCINE

被引：0
|
作者：
Jaramillo, Juan-Carlos [1 ]
Schneider, Martina [1 ]
Narciso, Marivic [1 ]
Hochreiter, Romana [1 ]
Bitzer, Annegret [1 ]
Mader, Robert [1 ]
Dubischar, Katrin [1 ]
Zoihsl, Oliver [1 ]
Wressnigg, Nina [1 ]
Eder-Lingelbach, Susanne [1 ]
机构：
[1] Valneva Austria GMBH, Vienna, Austria
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2021年 / 105卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
0848
引用
收藏
页码：271 / 272
页数：2
相关论文
共 50 条
  • [21] Development of Attenuated and Immunogenic Live-attenuated Respiratory Syncytial Virus Vaccine Candidates
    Hornung, Sandra L.
    Tran, Kim C.
    Teng, Michael N.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB120 - AB120
  • [22] Development of a novel equine influenza virus live-attenuated vaccine
    Rodriguez, Laura
    Reedy, Stephanie
    Nogales, Aitor
    Murcia, Pablo R.
    Chambers, Thomas M.
    Martinez-Sobrido, Luis
    [J]. VIROLOGY, 2018, 516 : 76 - 85
  • [23] POPULATION DIVERSITY-ALTERING MUTATIONS AS A METHOD FOR IMPROVING A LIVE-ATTENUATED CHIKUNGUNYA VIRUS VACCINE
    Weiss, Christopher M.
    Liu, Hongwei
    Riemersma, Kasen K.
    Coffey, Lark L.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 244 - 245
  • [24] Subgenomic flavivirus RNA as key target for live-attenuated vaccine development
    Doets, Kristel
    Pijlman, Gorben P.
    [J]. JOURNAL OF VIROLOGY, 2024, 98 (07)
  • [25] Live-attenuated bacteria as a cancer vaccine vector
    Toussaint, Bertrand
    Chauchet, Xavier
    Wang, Yan
    Polack, Benoit
    Le Gouellec, Audrey
    [J]. EXPERT REVIEW OF VACCINES, 2013, 12 (10) : 1139 - 1154
  • [26] Development of a live-attenuated chimeric vaccine against the emerging Usutu virus
    Wang, Zheng-Jian
    Zhang, Rong-Rong
    Wu, Mei
    Zhao, Hui
    Li, Xiao-Feng
    Ye, Qing
    Qin, Cheng-Feng
    [J]. VACCINE, 2024, 42 (06) : 1363 - 1371
  • [27] Preclinical Evaluation of a Live Attenuated Chikungunya Vaccine
    Livengood, Jill A.
    Partidos, Charalambos D.
    Plante, Kenneth
    Seymour, Rob
    Gorchakov, Rodion
    Varga, Laszlo
    Paykel, Joanna
    Weger, James
    Haller, Aurelia
    Stinchcomb, Dan T.
    Osorio, Jorge
    Weaver, Scott
    [J]. 5TH VACCINE AND ISV ANNUAL GLOBAL CONGRESS, 2012, 6 : 141 - 149
  • [28] Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine
    Halstead, Scott B.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (09) : 2158 - 2162
  • [29] Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
    Xiao-Feng Li
    Hao-Long Dong
    Hong-Jiang Wang
    Xing-Yao Huang
    Ye-Feng Qiu
    Xue Ji
    Qing Ye
    Chunfeng Li
    Yang Liu
    Yong-Qiang Deng
    Tao Jiang
    Gong Cheng
    Fu-Chun Zhang
    Andrew D. Davidson
    Ya-Jun Song
    Pei-Yong Shi
    Cheng-Feng Qin
    [J]. Nature Communications, 9
  • [30] Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
    Li, Xiao-Feng
    Dong, Hao-Long
    Wang, Hong-Jiang
    Huang, Xing-Yao
    Qiu, Ye-Feng
    Ji, Xue
    Ye, Qing
    Li, Chunfeng
    Liu, Yang
    Deng, Yong-Qiang
    Jiang, Tao
    Cheng, Gong
    Zhang, Fu-Chun
    Davidson, Andrew D.
    Song, Ya-Jun
    Shi, Pei-Yong
    Qin, Cheng-Feng
    [J]. NATURE COMMUNICATIONS, 2018, 9
12345